FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:AAK1-RPIA

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: AAK1-RPIA
FusionPDB ID: 68
FusionGDB2.0 ID: 68
HgeneTgene
Gene symbol

AAK1

RPIA

Gene ID

112268437

22934

Gene nameuncharacterized protein FLJ45252ribose 5-phosphate isomerase A
SynonymsAAK1RPI|RPIAD
Cytomap

-

2p11.2

Type of geneprotein-codingprotein-coding
Descriptionuncharacterized protein FLJ45252alternative protein AAK1ribose-5-phosphate isomerasephosphoriboisomeraseribose 5-phosphate epimerase
Modification date2020030320200327
UniProtAcc

Q2M2I8

Main function of 5'-partner protein: FUNCTION: Regulates clathrin-mediated endocytosis by phosphorylating the AP2M1/mu2 subunit of the adaptor protein complex 2 (AP-2) which ensures high affinity binding of AP-2 to cargo membrane proteins during the initial stages of endocytosis (PubMed:17494869, PubMed:11877457, PubMed:11877461, PubMed:12952931, PubMed:14617351, PubMed:25653444). Isoform 1 and isoform 2 display similar levels of kinase activity towards AP2M1 (PubMed:17494869). Preferentially, may phosphorylate substrates on threonine residues (PubMed:11877457, PubMed:18657069). Regulates phosphorylation of other AP-2 subunits as well as AP-2 localization and AP-2-mediated internalization of ligand complexes (PubMed:12952931). Phosphorylates NUMB and regulates its cellular localization, promoting NUMB localization to endosomes (PubMed:18657069). Binds to and stabilizes the activated form of NOTCH1, increases its localization in endosomes and regulates its transcriptional activity (PubMed:21464124). {ECO:0000269|PubMed:11877457, ECO:0000269|PubMed:11877461, ECO:0000269|PubMed:12952931, ECO:0000269|PubMed:14617351, ECO:0000269|PubMed:17494869, ECO:0000269|PubMed:18657069, ECO:0000269|PubMed:21464124, ECO:0000269|PubMed:25653444}.; FUNCTION: (Microbial infection) By regulating clathrin-mediated endocytosis, AAK1 plays a role in the entry of hepatitis C virus as well as for the lifecycle of other viruses such as Ebola and Dengue. {ECO:0000269|PubMed:25653444, ECO:0000305|PubMed:31136173}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000406297, ENST00000409068, 
ENST00000409085, ENST00000470281, 
ENST00000283646, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score19 X 13 X 11=27174 X 3 X 3=36
# samples 224
** MAII scorelog2(22/2717*10)=-3.62643913669732
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(4/36*10)=0.15200309344505
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
Fusion gene context

PubMed: AAK1 [Title/Abstract] AND RPIA [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: AAK1 [Title/Abstract] AND RPIA [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)AAK1(69783992)-RPIA(89028796), # samples:2
Anticipated loss of major functional domain due to fusion event.AAK1-RPIA seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
AAK1-RPIA seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
AAK1-RPIA seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
AAK1-RPIA seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:69783992/chr2:89028796)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across AAK1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across RPIA (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000409068AAK1chr269783992-ENST00000283646RPIAchr289028796+19875962151129304
ENST00000409085AAK1chr269783992-ENST00000283646RPIAchr289028796+20506592781192304
ENST00000406297AAK1chr269783992-ENST00000283646RPIAchr289028796+20506592781192304

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000409068ENST00000283646AAK1chr269783992-RPIAchr289028796+0.0008594540.9991405
ENST00000409085ENST00000283646AAK1chr269783992-RPIAchr289028796+0.00107150.9989285
ENST00000406297ENST00000283646AAK1chr269783992-RPIAchr289028796+0.00107150.9989285

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for AAK1-RPIA

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
AAK1chr269783992RPIAchr289028796596127HDLQVCKREIQIMARQLILQYGLTLS
AAK1chr269783992RPIAchr289028796659127HDLQVCKREIQIMARQLILQYGLTLS

Top

Potential FusionNeoAntigen Information of AAK1-RPIA in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
AAK1-RPIA_69783992_89028796.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
AAK1-RPIAchr269783992chr289028796659HLA-B52:01IQIMARQL0.79470.6813917
AAK1-RPIAchr269783992chr289028796659HLA-B15:01MARQLILQY0.99960.85411221
AAK1-RPIAchr269783992chr289028796659HLA-B15:25MARQLILQY0.99950.91381221
AAK1-RPIAchr269783992chr289028796659HLA-B15:02MARQLILQY0.99880.92011221
AAK1-RPIAchr269783992chr289028796659HLA-B15:17MARQLILQY0.99790.84011221
AAK1-RPIAchr269783992chr289028796659HLA-B08:01QIMARQLIL0.99670.93291019
AAK1-RPIAchr269783992chr289028796659HLA-B35:08MARQLILQY0.99660.93991221
AAK1-RPIAchr269783992chr289028796659HLA-B57:01MARQLILQY0.99610.94581221
AAK1-RPIAchr269783992chr289028796659HLA-B08:09QIMARQLIL0.99410.80241019
AAK1-RPIAchr269783992chr289028796659HLA-B27:05KREIQIMAR0.9940.7649615
AAK1-RPIAchr269783992chr289028796659HLA-B35:01MARQLILQY0.99040.92591221
AAK1-RPIAchr269783992chr289028796659HLA-B58:02MARQLILQY0.98880.90711221
AAK1-RPIAchr269783992chr289028796659HLA-B15:16MARQLILQY0.98690.70741221
AAK1-RPIAchr269783992chr289028796659HLA-B35:05MARQLILQY0.97690.58691221
AAK1-RPIAchr269783992chr289028796659HLA-B15:03MARQLILQY0.97020.75771221
AAK1-RPIAchr269783992chr289028796659HLA-B58:01MARQLILQY0.96620.81421221
AAK1-RPIAchr269783992chr289028796659HLA-B13:01IQIMARQLI0.58740.9402918
AAK1-RPIAchr269783992chr289028796659HLA-A32:13MARQLILQY0.4450.83711221
AAK1-RPIAchr269783992chr289028796659HLA-B52:01IQIMARQLI0.39860.8054918
AAK1-RPIAchr269783992chr289028796659HLA-B15:01IMARQLILQY0.99990.80131121
AAK1-RPIAchr269783992chr289028796659HLA-B15:25IMARQLILQY0.9970.86421121
AAK1-RPIAchr269783992chr289028796659HLA-B44:03REIQIMARQL0.97290.9432717
AAK1-RPIAchr269783992chr289028796659HLA-B15:21MARQLILQY0.99890.92891221
AAK1-RPIAchr269783992chr289028796659HLA-B15:07MARQLILQY0.99850.58021221
AAK1-RPIAchr269783992chr289028796659HLA-B15:05MARQLILQY0.99620.88261221
AAK1-RPIAchr269783992chr289028796659HLA-B27:14KREIQIMAR0.99360.6497615
AAK1-RPIAchr269783992chr289028796659HLA-B15:31MARQLILQY0.99010.89041221
AAK1-RPIAchr269783992chr289028796659HLA-C07:19MARQLILQY0.97050.59631221
AAK1-RPIAchr269783992chr289028796659HLA-C12:16MARQLILQY0.93940.95881221
AAK1-RPIAchr269783992chr289028796659HLA-C07:95MARQLILQY0.93910.61671221
AAK1-RPIAchr269783992chr289028796659HLA-B15:04MARQLILQY0.90730.86111221
AAK1-RPIAchr269783992chr289028796659HLA-C15:04MARQLILQY0.85490.76951221
AAK1-RPIAchr269783992chr289028796659HLA-C07:05MARQLILQY0.83260.95341221
AAK1-RPIAchr269783992chr289028796659HLA-C03:14MARQLILQY0.72030.91871221
AAK1-RPIAchr269783992chr289028796659HLA-B27:03KREIQIMAR0.70570.7887615
AAK1-RPIAchr269783992chr289028796659HLA-C12:12MARQLILQY0.64760.94791221
AAK1-RPIAchr269783992chr289028796659HLA-C12:04MARQLILQY0.59350.98741221
AAK1-RPIAchr269783992chr289028796659HLA-C06:03MARQLILQY0.58560.99011221
AAK1-RPIAchr269783992chr289028796659HLA-B51:07IQIMARQLI0.36290.7029918
AAK1-RPIAchr269783992chr289028796659HLA-B15:07IMARQLILQY0.99970.57371121
AAK1-RPIAchr269783992chr289028796659HLA-B15:04IMARQLILQY0.9940.83911121
AAK1-RPIAchr269783992chr289028796659HLA-B15:33MARQLILQY0.99960.85411221
AAK1-RPIAchr269783992chr289028796659HLA-B15:125MARQLILQY0.99960.85411221
AAK1-RPIAchr269783992chr289028796659HLA-B15:34MARQLILQY0.99960.85411221
AAK1-RPIAchr269783992chr289028796659HLA-B15:135MARQLILQY0.99950.8541221
AAK1-RPIAchr269783992chr289028796659HLA-B15:27MARQLILQY0.99950.85321221
AAK1-RPIAchr269783992chr289028796659HLA-B15:39MARQLILQY0.99940.82891221
AAK1-RPIAchr269783992chr289028796659HLA-B15:08MARQLILQY0.9990.791221
AAK1-RPIAchr269783992chr289028796659HLA-B15:11MARQLILQY0.9990.78341221
AAK1-RPIAchr269783992chr289028796659HLA-B35:11MARQLILQY0.99860.92811221
AAK1-RPIAchr269783992chr289028796659HLA-B15:50MARQLILQY0.99850.89811221
AAK1-RPIAchr269783992chr289028796659HLA-B35:43MARQLILQY0.99850.8011221
AAK1-RPIAchr269783992chr289028796659HLA-B15:35MARQLILQY0.99830.74641221
AAK1-RPIAchr269783992chr289028796659HLA-B15:24MARQLILQY0.99790.75981221
AAK1-RPIAchr269783992chr289028796659HLA-B15:12MARQLILQY0.9970.78381221
AAK1-RPIAchr269783992chr289028796659HLA-B57:04MARQLILQY0.99680.71331221
AAK1-RPIAchr269783992chr289028796659HLA-B08:18QIMARQLIL0.99670.93291019
AAK1-RPIAchr269783992chr289028796659HLA-B15:53MARQLILQY0.99620.82881221
AAK1-RPIAchr269783992chr289028796659HLA-B57:10MARQLILQY0.99610.94581221
AAK1-RPIAchr269783992chr289028796659HLA-B15:20MARQLILQY0.99610.92981221
AAK1-RPIAchr269783992chr289028796659HLA-B35:28MARQLILQY0.99510.93081221
AAK1-RPIAchr269783992chr289028796659HLA-B58:06MARQLILQY0.99340.77351221
AAK1-RPIAchr269783992chr289028796659HLA-B35:30MARQLILQY0.99180.82451221
AAK1-RPIAchr269783992chr289028796659HLA-B35:17MARQLILQY0.99180.82451221
AAK1-RPIAchr269783992chr289028796659HLA-B35:23MARQLILQY0.99120.92651221
AAK1-RPIAchr269783992chr289028796659HLA-B27:10KREIQIMAR0.99090.8524615
AAK1-RPIAchr269783992chr289028796659HLA-B35:20MARQLILQY0.99090.94281221
AAK1-RPIAchr269783992chr289028796659HLA-B35:77MARQLILQY0.99040.92591221
AAK1-RPIAchr269783992chr289028796659HLA-B15:13MARQLILQY0.98720.54081221
AAK1-RPIAchr269783992chr289028796659HLA-B35:24MARQLILQY0.98030.91341221
AAK1-RPIAchr269783992chr289028796659HLA-B08:12QIMARQLIL0.96730.95541019
AAK1-RPIAchr269783992chr289028796659HLA-B15:54MARQLILQY0.96070.80921221
AAK1-RPIAchr269783992chr289028796659HLA-C07:17MARQLILQY0.95760.9631221
AAK1-RPIAchr269783992chr289028796659HLA-C03:02MARQLILQY0.95410.9671221
AAK1-RPIAchr269783992chr289028796659HLA-C07:01MARQLILQY0.94450.60711221
AAK1-RPIAchr269783992chr289028796659HLA-B48:02MARQLILQY0.93930.921221
AAK1-RPIAchr269783992chr289028796659HLA-A30:01MARQLILQY0.91740.74561221
AAK1-RPIAchr269783992chr289028796659HLA-C15:09MARQLILQY0.85490.76951221
AAK1-RPIAchr269783992chr289028796659HLA-B15:68MARQLILQY0.84020.51961221
AAK1-RPIAchr269783992chr289028796659HLA-C12:02MARQLILQY0.82450.9631221
AAK1-RPIAchr269783992chr289028796659HLA-B18:04MARQLILQY0.76420.90141221
AAK1-RPIAchr269783992chr289028796659HLA-C12:03MARQLILQY0.74020.9771221
AAK1-RPIAchr269783992chr289028796659HLA-C16:04MARQLILQY0.67060.981221
AAK1-RPIAchr269783992chr289028796659HLA-A25:01MARQLILQY0.64990.82061221
AAK1-RPIAchr269783992chr289028796659HLA-C16:01MARQLILQY0.52820.97121221
AAK1-RPIAchr269783992chr289028796659HLA-C02:02MARQLILQY0.51090.95611221
AAK1-RPIAchr269783992chr289028796659HLA-C02:10MARQLILQY0.51090.95611221
AAK1-RPIAchr269783992chr289028796659HLA-B18:07MARQLILQY0.46930.84461221
AAK1-RPIAchr269783992chr289028796659HLA-B18:08MARQLILQY0.46270.81811221
AAK1-RPIAchr269783992chr289028796659HLA-C16:02MARQLILQY0.42890.98581221
AAK1-RPIAchr269783992chr289028796659HLA-B15:27IMARQLILQY0.99990.81831121
AAK1-RPIAchr269783992chr289028796659HLA-B15:33IMARQLILQY0.99990.80131121
AAK1-RPIAchr269783992chr289028796659HLA-B15:135IMARQLILQY0.99990.82571121
AAK1-RPIAchr269783992chr289028796659HLA-B15:34IMARQLILQY0.99990.80131121
AAK1-RPIAchr269783992chr289028796659HLA-B15:125IMARQLILQY0.99990.80131121
AAK1-RPIAchr269783992chr289028796659HLA-B15:35IMARQLILQY0.99960.74731121
AAK1-RPIAchr269783992chr289028796659HLA-B15:39IMARQLILQY0.99660.75431121
AAK1-RPIAchr269783992chr289028796659HLA-B40:04REIQIMARQL0.99430.6833717
AAK1-RPIAchr269783992chr289028796659HLA-B44:26REIQIMARQL0.97290.9432717
AAK1-RPIAchr269783992chr289028796659HLA-B44:07REIQIMARQL0.97290.9432717
AAK1-RPIAchr269783992chr289028796659HLA-B44:13REIQIMARQL0.97290.9432717
AAK1-RPIAchr269783992chr289028796659HLA-B41:03REIQIMARQL0.70660.7468717

Top

Potential FusionNeoAntigen Information of AAK1-RPIA in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
AAK1-RPIA_69783992_89028796.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
AAK1-RPIAchr269783992chr289028796659DRB1-1113CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1113KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1113VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1113REIQIMARQLILQYG722
AAK1-RPIAchr269783992chr289028796659DRB1-1117CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1117KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1117VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1118CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1118KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1134CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1134KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1142CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1142KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1152CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1152KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1152VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1157CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1157KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1184CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1184KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1189CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1189KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1189VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1192KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1192CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1203CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1203KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1204CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1204KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1209CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1209KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1306CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1306KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1309CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1309KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-13100CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1331CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1331KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1344CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1344KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1346CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1361KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1361CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1377CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1377KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1377VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1386KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1401CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1401KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1401VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1401QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1404CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1404KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1404VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1405CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1405KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1405VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1406CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1406KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1407CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1407KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1408CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1408KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1408VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1411CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1411KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1411VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1414CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1414KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1416CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1416KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1417CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1417KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1418CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1418KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1418VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1420CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1420KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1421CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1421KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1423CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1423KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1423VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1426CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1426KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1426VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1426QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1428CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1428KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1428VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1428QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1429CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1429KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1430CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1430KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1431CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1431KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1431VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1431QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1432CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1432KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1432VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1432QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1433CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1433KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1434CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1434KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1434VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1435CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1435KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1435VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1435QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1436CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1436KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1437CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1437KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1438CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1438KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1438VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1439CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1439KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1442CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1442KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1443CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1443KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1443VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1444CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1444KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1445CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1445KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1445VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1449CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1450CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1450KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1450VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1452CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1452KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1454CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1454KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1454VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1454QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1455CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1455KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1455VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1456CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1456KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1456VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1458CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1458KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1458VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1458QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1459CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1459KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1459VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1460CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1460KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1460VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1460QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1461CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1461KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1461VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1462CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1462KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1464CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1464KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1464VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1465CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1465KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1465VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1468CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1468KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1470CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1470KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1471CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1471KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1471VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1472CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1472KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1472VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1474CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1474KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1475CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1475KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1475VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1480CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1480KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1481CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1481KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1481VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1482CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1482KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1482VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1483CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1483KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1486CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1486KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1486VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1486QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1487CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1487KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1487VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1487QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1488CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1488KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1488VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1488QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1490CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1490KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1490VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1490QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1491CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1491KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1491VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1493CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1493KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1495CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1495KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1495VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1496CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1496KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1496VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1497CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1497KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1497VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1497QVCKREIQIMARQLI318
AAK1-RPIAchr269783992chr289028796659DRB1-1499CKREIQIMARQLILQ520
AAK1-RPIAchr269783992chr289028796659DRB1-1499KREIQIMARQLILQY621
AAK1-RPIAchr269783992chr289028796659DRB1-1499VCKREIQIMARQLIL419
AAK1-RPIAchr269783992chr289028796659DRB1-1499QVCKREIQIMARQLI318

Top

Fusion breakpoint peptide structures of AAK1-RPIA

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
4552KREIQIMARQLILQAAK1RPIAchr269783992chr289028796659

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of AAK1-RPIA

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN4552KREIQIMARQLILQ-7.9962-8.1096
HLA-B14:023BVN4552KREIQIMARQLILQ-5.70842-6.74372
HLA-B52:013W394552KREIQIMARQLILQ-6.83737-6.95077
HLA-B52:013W394552KREIQIMARQLILQ-4.4836-5.5189
HLA-A11:014UQ24552KREIQIMARQLILQ-10.0067-10.1201
HLA-A11:014UQ24552KREIQIMARQLILQ-9.03915-10.0745
HLA-A24:025HGA4552KREIQIMARQLILQ-6.56204-6.67544
HLA-A24:025HGA4552KREIQIMARQLILQ-5.42271-6.45801
HLA-B44:053DX84552KREIQIMARQLILQ-7.85648-8.89178
HLA-B44:053DX84552KREIQIMARQLILQ-5.3978-5.5112
HLA-A02:016TDR4552KREIQIMARQLILQ-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of AAK1-RPIA

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
AAK1-RPIAchr269783992chr2890287961019QIMARQLILCAGATAATGGCCCGCCAGCTCATCCTG
AAK1-RPIAchr269783992chr2890287961121IMARQLILQYATAATGGCCCGCCAGCTCATCCTGCAGTAT
AAK1-RPIAchr269783992chr2890287961221MARQLILQYATGGCCCGCCAGCTCATCCTGCAGTAT
AAK1-RPIAchr269783992chr289028796615KREIQIMARAAGAGAGAAATCCAGATAATGGCCCGC
AAK1-RPIAchr269783992chr289028796717REIQIMARQLAGAGAAATCCAGATAATGGCCCGCCAGCTC
AAK1-RPIAchr269783992chr289028796917IQIMARQLATCCAGATAATGGCCCGCCAGCTC
AAK1-RPIAchr269783992chr289028796918IQIMARQLIATCCAGATAATGGCCCGCCAGCTCATC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
AAK1-RPIAchr269783992chr289028796318QVCKREIQIMARQLICAGGTGTGCAAGAGAGAAATCCAGATAATGGCCCGCCAGCTCATC
AAK1-RPIAchr269783992chr289028796419VCKREIQIMARQLILGTGTGCAAGAGAGAAATCCAGATAATGGCCCGCCAGCTCATCCTG
AAK1-RPIAchr269783992chr289028796520CKREIQIMARQLILQTGCAAGAGAGAAATCCAGATAATGGCCCGCCAGCTCATCCTGCAG
AAK1-RPIAchr269783992chr289028796621KREIQIMARQLILQYAAGAGAGAAATCCAGATAATGGCCCGCCAGCTCATCCTGCAGTAT
AAK1-RPIAchr269783992chr289028796722REIQIMARQLILQYGAGAGAAATCCAGATAATGGCCCGCCAGCTCATCCTGCAGTATGGC

Top

Information of the samples that have these potential fusion neoantigens of AAK1-RPIA

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
LIHCAAK1-RPIAchr269783992ENST00000406297chr289028796ENST00000283646TCGA-DD-A3A5-01A

Top

Potential target of CAR-T therapy development for AAK1-RPIA

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to AAK1-RPIA

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to AAK1-RPIA

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource